Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Research Reviews
  4. Fast Track Articles
  5. Fast Track Article
image of Platelet-rich Plasma for the Treatment of Neuropathic Pain: A Systematic Review

Abstract

Background

Neuropathic pain (NP) presents a significant actual public health challenge. Traditional treatments primarily involve medications, but these approaches frequently yield unsatisfactory results, highlighting the need to explore alternative therapies, such as platelet-rich plasma (PRP), an autologous plasma derivative enriched with platelets.

Objective

This article aims to systematically review the literature and provide an updated assessment of the efficacy and safety of PRP treatment for NP.

Methods

Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched databases, including Web of Science, Embase, PubMed, Scopus, and Cochrane Library. We assessed bias risk using the Cochrane Risk of Bias 2 tool (RoB2).

Results

Among 1230 studies identified, 12 randomized trials meeting eligibility criteria were included. Due to substantial heterogeneity, pairwise meta-analysis and intervention ranking were found to be unfeasible. Most trials suggest PRP is effective in relieving NP, with no reported serious complications or significant PRP-related adverse effects. However, these findings were compromised by methodological heterogeneity and study inconsistency.

Conclusion

PRP has shown to be promising as a safe therapeutic option for managing NP. Future studies should prioritize improved rigor and reproducibility for more stringent conclusions.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdrr/10.2174/0125899775321724240926114704
2024-10-14
2025-05-08

  • From This Site

    /content/journals/cdrr/10.2174/0125899775321724240926114704
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Smith B.H. Hébert H.L. Veluchamy A. Neuropathic pain in the community: prevalence, impact, and risk factors. Pain 2020 161 Suppl. 1 S127 S137 10.1097/j.pain.0000000000001824 33090746
    [Google Scholar]
  2. Doth A.H. Hansson P.T. Jensen M.P. Taylor R.S. The burden of neuropathic pain: A systematic review and meta-analysis of health utilities. Pain 2010 149 2 338 344 10.1016/j.pain.2010.02.034 20227832
    [Google Scholar]
  3. Szewczyk A. Jamroz-Wiśniewska A. Haratym N. Rejdak K. Neuropathic pain and chronic pain as an underestimated interdisciplinary problem. Int. J. Occup. Med. Environ. Health 2022 35 3 249 264 10.13075/ijomeh.1896.01676 35040826
    [Google Scholar]
  4. van Hecke O. Austin S.K. Khan R.A. Smith B.H. Torrance N. Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain 2014 155 4 654 662 10.1016/j.pain.2013.11.013 24291734
    [Google Scholar]
  5. Bouhassira D. Lantéri-Minet M. Attal N. Laurent B. Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008 136 3 380 387 10.1016/j.pain.2007.08.013 17888574
    [Google Scholar]
  6. Blanco E Galvez R Zamorano E López V Pérez M Prevalencia del dolor neuropathic (DN), según DN4, en attention primaria. SEMERGEN - Medicina de Familia 2012 38 203 10 10.1016/j.semerg.2011.10.012
    [Google Scholar]
  7. Torrance N. Smith B.H. Bennett M.I. Lee A.J. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J. Pain 2006 7 4 281 289 10.1016/j.jpain.2005.11.008 16618472
    [Google Scholar]
  8. Dieleman J.P. Kerklaan J. Huygen F.J.P.M. Bouma P.A.D. Sturkenboom M.C.J.M. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008 137 3 681 688 10.1016/j.pain.2008.03.002 18439759
    [Google Scholar]
  9. Mills SEE, Mills S.E.E. Nicolson K.P. Smith B.H. Chronic pain: A review of its epidemiology and associated factors in population-based studies. Br. J. Anaesth. 2019 123 2 e273 e283 10.1016/j.bja.2019.03.023 31079836
    [Google Scholar]
  10. IASP. Pain Terms. International Association for the Study of Pain. 2012 Available from: https://www.iasp-pain.org/resources/terminology/
  11. Scholz J. Finnerup N.B. Attal N. Aziz Q. Baron R. Bennett M.I. Benoliel R. Cohen M. Cruccu G. Davis K.D. Evers S. First M. Giamberardino M.A. Hansson P. Kaasa S. Korwisi B. Kosek E. Lavand’homme P. Nicholas M. Nurmikko T. Perrot S. Raja S.N. Rice A.S.C. Rowbotham M.C. Schug S. Simpson D.M. Smith B.H. Svensson P. Vlaeyen J.W.S. Wang S.J. Barke A. Rief W. Treede R.D. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain 2019 160 1 53 59 10.1097/j.pain.0000000000001365 30586071
    [Google Scholar]
  12. Attal N. Bouhassira D. Colvin L. Advances and challenges in neuropathic pain: A narrative review and future directions. Br. J. Anaesth. 2023 131 1 79 92 10.1016/j.bja.2023.04.021 37210279
    [Google Scholar]
  13. Barke A. Korwisi B. Jakob R. Konstanjsek N. Rief W. Treede R.D. Classification of chronic pain for the International Classification of Diseases (ICD-11): results of the 2017 international World Health Organization field testing. Pain 2022 163 2 e310 e318 10.1097/j.pain.0000000000002287 33863861
    [Google Scholar]
  14. Baskozos G. Hébert H.L. Pascal M.M.V. Themistocleous A.C. Macfarlane G.J. Wynick D. Bennett D.L.H. Smith B.H. Epidemiology of neuropathic pain: An analysis of prevalence and associated factors in UK Biobank. Pain Rep. 2023 8 2 e1066 10.1097/PR9.0000000000001066 37090682
    [Google Scholar]
  15. Treede R.D. Rief W. Barke A. Aziz Q. Bennett M.I. Benoliel R. Cohen M. Evers S. Finnerup N.B. First M.B. Giamberardino M.A. Kaasa S. Korwisi B. Kosek E. Lavand’homme P. Nicholas M. Perrot S. Scholz J. Schug S. Smith B.H. Svensson P. Vlaeyen J.W.S. Wang S.J. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019 160 1 19 27 10.1097/j.pain.0000000000001384 30586067
    [Google Scholar]
  16. Szok D. Tajti J. Nyári A. Vécsei L. Trojano L. Therapeutic Approaches for Peripheral and Central Neuropathic Pain. Behav. Neurol. 2019 2019 1 13 10.1155/2019/8685954 31871494
    [Google Scholar]
  17. Bannister K. Sachau J. Baron R. Dickenson A.H. Neuropathic Pain: Mechanism-Based Therapeutics. Annu. Rev. Pharmacol. Toxicol. 2020 60 1 257 274 10.1146/annurev‑pharmtox‑010818‑021524 31914896
    [Google Scholar]
  18. Finnerup N.B. Kuner R. Jensen T.S. Neuropathic Pain: From Mechanisms to Treatment. Physiol. Rev. 2021 101 1 259 301 10.1152/physrev.00045.2019 32584191
    [Google Scholar]
  19. Kuffler D.P. Mechanisms for Reducing Neuropathic Pain. Mol. Neurobiol. 2020 57 1 67 87 10.1007/s12035‑019‑01757‑9 31813127
    [Google Scholar]
  20. Attal N. Pharmacological treatments of neuropathic pain: The latest recommendations. Rev. Neurol. (Paris) 2019 175 1-2 46 50 10.1016/j.neurol.2018.08.005 30318260
    [Google Scholar]
  21. Cruccu G. Truini A. A review of Neuropathic Pain: From Guidelines to Clinical Practice. Pain Ther. 2017 6 S1 Suppl. 1 35 42 10.1007/s40122‑017‑0087‑0 29178033
    [Google Scholar]
  22. Colloca L. Ludman T. Bouhassira D. Baron R. Dickenson A.H. Yarnitsky D. Freeman R. Truini A. Attal N. Finnerup N.B. Eccleston C. Kalso E. Bennett D.L. Dworkin R.H. Raja S.N. Neuropathic pain. Nat. Rev. Dis. Primers 2017 3 1 17002 10.1038/nrdp.2017.2 28205574
    [Google Scholar]
  23. Eisenberg E. Suzan E. Drug combinations in the treatment of neuropathic pain. Curr. Pain Headache Rep. 2014 18 12 463 10.1007/s11916‑014‑0463‑y 25298046
    [Google Scholar]
  24. Rosenberger D.C. Blechschmidt V. Timmerman H. Wolff A. Treede R.D. Challenges of neuropathic pain: focus on diabetic neuropathy. J. Neural Transm. (Vienna) 2020 127 4 589 624 10.1007/s00702‑020‑02145‑7 32036431
    [Google Scholar]
  25. Petroianu G.A. Aloum L. Adem A. Neuropathic pain: Mechanisms and therapeutic strategies. Front. Cell Dev. Biol. 2023 11 1072629 10.3389/fcell.2023.1072629 36727110
    [Google Scholar]
  26. Thouaye M. Yalcin I. Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons. Pharmacol. Ther. 2023 251 108546 10.1016/j.pharmthera.2023.108546 37832728
    [Google Scholar]
  27. Golzari S.E.J. Soleimanpour H. Mahmoodpoor A. Safari S. Ala A. Lidocaine and pain management in the emergency department: A review article. Anesth. Pain Med. 2014 3 3 e15444 10.5812/aapm.15444 24660158
    [Google Scholar]
  28. Ghojazadeh M. Sanaie S. Parsian Z. Najafizadeh R. Soleimanpour H. Use of Lidocaine for Pain Management in the Emergency Medicine: A Systematic Review and Meta-Analysis. Ulum-i Daruyi 2019 25 3 177 183 10.15171/PS.2019.48
    [Google Scholar]
  29. Soleimanpour H. Imani F. Dolati S. Soleimanpour M. Shahsavarinia K. Management of pain using magnesium sulphate: A narrative review. Postgrad. Med. 2022 134 3 260 266 10.1080/00325481.2022.2035092 35086408
    [Google Scholar]
  30. Morteza Bagi H. Ahmadi S. Tarighat F. Rahbarghazi R. Soleimanpour H. Interplay between exosomes and autophagy machinery in pain management: State of the art. Neurobiol. Pain 2022 12 100095 10.1016/j.ynpai.2022.100095 35720640
    [Google Scholar]
  31. Latifi K. Negaresh M. Javanshir N. Safari S. The Advent of Artificial Intelligence in Anesthesiology and Pain Management: A Review Article. International Journal of Drug Research in Clinics 2023 1 e14 10.34172/ijdrc.2023.e14
    [Google Scholar]
  32. Cavalli E. Mammana S. Nicoletti F. Bramanti P. Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int. J. Immunopathol. Pharmacol. 2019 33 10.1177/2058738419838383 30900486
    [Google Scholar]
  33. Buchheit T. Huh Y. Maixner W. Cheng J. Ji R.R. Neuroimmune modulation of pain and regenerative pain medicine. J. Clin. Invest. 2020 130 5 2164 2176 10.1172/JCI134439 32250346
    [Google Scholar]
  34. Akeda K. Yamada J. Linn E. Sudo A. Masuda K. Platelet-rich plasma in the management of chronic low back pain: A critical review. J. Pain Res. 2019 12 753 767 10.2147/JPR.S153085 30881089
    [Google Scholar]
  35. Knezevic N.N. Candido K.D. Desai R. Kaye A.D. Is Platelet-Rich Plasma a Future Therapy in Pain Management? Med. Clin. North Am. 2016 100 1 199 217 10.1016/j.mcna.2015.08.014 26614728
    [Google Scholar]
  36. Grossen A.A. Lee B.J. Shi H.H. Shakir H.J. Cornett E.M. Kaye A.D. Platelet-Rich Plasma Injections: Pharmacological and Clinical Considerations in Pain Management. Curr. Pain Headache Rep. 2022 26 10 741 749 10.1007/s11916‑022‑01082‑2 36087238
    [Google Scholar]
  37. Mautner K. Malanga G.A. Smith J. Shiple B. Ibrahim V. Sampson S. Bowen J.E. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R 2015 7 4S Suppl. S53 S59 10.1016/j.pmrj.2015.02.005 25864661
    [Google Scholar]
  38. Bennell K.L. Hunter D.J. Paterson K.L. Platelet-Rich Plasma for the Management of Hip and Knee Osteoarthritis. Curr. Rheumatol. Rep. 2017 19 5 24 10.1007/s11926‑017‑0652‑x 28386761
    [Google Scholar]
  39. Everts P. Onishi K. Jayaram P. Lana J.F. Mautner K. Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int. J. Mol. Sci. 2020 21 20 7794 10.3390/ijms21207794 33096812
    [Google Scholar]
  40. Tang J.Z. Nie M.J. Zhao J.Z. Zhang G.C. Zhang Q. Wang B. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: A meta-analysis. J. Orthop. Surg. Res. 2020 15 1 403 10.1186/s13018‑020‑01919‑9 32912243
    [Google Scholar]
  41. Migliorini F. Driessen A. Quack V. Sippel N. Cooper B. Mansy Y.E. Tingart M. Eschweiler J. Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: A Bayesian network meta-analysis. Arch. Orthop. Trauma Surg. 2021 141 9 1473 1490 10.1007/s00402‑020‑03551‑y 32725315
    [Google Scholar]
  42. Filardo G. Previtali D. Napoli F. Candrian C. Zaffagnini S. Grassi A. PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. Cartilage 2021 13 1_suppl 364S 375S 10.1177/1947603520931170 32551947
    [Google Scholar]
  43. Lin H.W. Tam K.W. Liou T.H. Rau C.L. Huang S.W. Hsu T.H. Efficacy of Platelet-Rich Plasma Injection on Range of Motion, Pain, and Disability in Patients With Adhesive Capsulitis: A Systematic Review and Meta-analysis. Arch. Phys. Med. Rehabil. 2023 104 12 2109 2122 10.1016/j.apmr.2023.03.032 37119955
    [Google Scholar]
  44. Chen X.T. Fang W. Jones I.A. Heckmann N.D. Park C. Vangsness C.T. Jr The Efficacy of Platelet-Rich Plasma for Improving Pain and Function in Lateral Epicondylitis: A Systematic Review and Meta-analysis with Risk-of-Bias Assessment. Arthroscopy 2021 37 9 2937 2952 10.1016/j.arthro.2021.04.061 33964386
    [Google Scholar]
  45. Barman A. Sinha M.K. Sahoo J. Jena D. Patel V. Patel S. Bhattacharjee S. Baral D. Platelet-rich plasma injection in the treatment of patellar tendinopathy: A systematic review and meta-analysis. Knee Surg. Relat. Res. 2022 34 1 22 10.1186/s43019‑022‑00151‑5 35509070
    [Google Scholar]
  46. Jain D. Goyal T. Verma N. Paswan A.K. Dubey R.K. Intradiscal Platelet-Rich Plasma Injection for Discogenic Low Back Pain and Correlation with Platelet Concentration: A Prospective Clinical Trial. Pain Med. 2020 21 11 2719 2725 10.1093/pm/pnaa254 32869064
    [Google Scholar]
  47. Tuakli-Wosornu Y.A. Terry A. Boachie-Adjei K. Harrison J.R. Gribbin C.K. LaSalle E.E. Nguyen J.T. Solomon J.L. Lutz G.E. Lumbar Intradiskal Platelet‐Rich Plasma (PRP) Injections: A Prospective, Double‐Blind, Randomized Controlled Study. PM R 2016 8 1 1 10 10.1016/j.pmrj.2015.08.010 26314234
    [Google Scholar]
  48. Wang S. Liu Z. Wang J. Cheng L. Hu J. Tang J. Platelet-rich plasma (PRP) in nerve repair. Regen. Ther. 2024 27 244 250 10.1016/j.reth.2024.03.017 38586873
    [Google Scholar]
  49. Yu W. Wang J. Yin J. Platelet-rich plasma: A promising product for treatment of peripheral nerve regeneration after nerve injury. Int. J. Neurosci. 2011 121 4 176 180 10.3109/00207454.2010.544432 21244302
    [Google Scholar]
  50. Buntragulpoontawee M. Chang K.V. Vitoonpong T. Pornjaksawan S. Kitisak K. Saokaew S. Kanchanasurakit S. The Effectiveness and Safety of Commonly Used Injectates for Ultrasound-Guided Hydrodissection Treatment of Peripheral Nerve Entrapment Syndromes: A Systematic Review. Front. Pharmacol. 2021 11 621150 10.3389/fphar.2020.621150 33746745
    [Google Scholar]
  51. Davey M.S. Davey M.G. Hurley E.T. Cassidy J.T. Mullett H. McInerney N.M. Galbraith J.G. Platelet-rich plasma in non-operative management of mild to moderate carpal tunnel syndrome – A systematic review & meta-analysis of short-term outcomes. J. Orthop. 2021 25 155 161 10.1016/j.jor.2021.05.004 35068775
    [Google Scholar]
  52. Jiang J. Xing F. Luo R. Liu M. Effectiveness of Platelet-Rich Plasma for Patients With Carpal Tunnel Syndrome: A Systematic Review and meta-Analysis of Current Evidence in Randomized Controlled Trials. Front. Pharmacol. 2022 13 834213 10.3389/fphar.2022.834213 35571114
    [Google Scholar]
  53. Gao N. Yan L. Ai F. Kang J. Wang L. Weng Y. Comparison of the Short-Term Clinical Effectiveness of 5% Dextrose Water, Platelet-rich Plasma and Corticosteroid Injections for Carpal Tunnel Syndrome: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. Arch. Phys. Med. Rehabil. 2023 104 5 799 811 10.1016/j.apmr.2022.11.009 36529261
    [Google Scholar]
  54. Klifto K.M. Klifto C.S. Pidgeon T.S. Richard M.J. Ruch D.S. Colbert S.H. Platelet-Rich Plasma versus Corticosteroid Injections for the Treatment of Mild-to-Moderate Carpal Tunnel Syndrome: A Markov Cost-Effectiveness Decision Analysis. Hand (N. Y.) 2024 19 1 113 127 10.1177/15589447221092056 35603672
    [Google Scholar]
  55. Hassanien M. Elawamy A. Kamel E.Z. Khalifa W.A. Abolfadl G.M. Roushdy A.S.I. El Zohne R.A. Makarem Y.S. Perineural platelet-rich plasma for diabetic neuropathic pain, could it make a difference? Pain Med. 2020 21 4 757 765 10.1093/pm/pnz140 31298289
    [Google Scholar]
  56. Sánchez M. Anitua E. Delgado D. Sanchez P. Prado R. Orive G. Padilla S. Platelet-rich plasma, a source of autologous growth factors and biomimetic scaffold for peripheral nerve regeneration. Expert Opin. Biol. Ther. 2017 17 2 197 212 10.1080/14712598.2017.1259409 27845852
    [Google Scholar]
  57. Kim H.J. Yeom J.S. Koh Y.G. Yeo J.E. Kang K.T. Kang Y.M. Chang B.S. Lee C.K. Anti‐inflammatory effect of platelet‐rich plasma on nucleus pulposus cells with response of TNF‐α and IL‐1. J. Orthop. Res. 2014 32 4 551 556 10.1002/jor.22532 24338609
    [Google Scholar]
  58. Page M.J. McKenzie J.E. Bossuyt P.M. Boutron I. Hoffmann T.C. Mulrow C.D. Shamseer L. Tetzlaff J.M. Akl E.A. Brennan S.E. Chou R. Glanville J. Grimshaw J.M. Hróbjartsson A. Lalu M.M. Li T. Loder E.W. Mayo-Wilson E. McDonald S. McGuinness L.A. Stewart L.A. Thomas J. Tricco A.C. Welch V.A. Whiting P. Moher D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int. J. Surg. 2021 88 105906 10.1016/j.ijsu.2021.105906 33789826
    [Google Scholar]
  59. Higgins J. Thomas J. Chandler J. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated march 2023). 2023
    [Google Scholar]
  60. Available from: https://rayyan.qcri.org/
  61. Jensen T.S. Baron R. Haanpää M. Kalso E. Loeser J.D. Rice A.S.C. Treede R.D. A new definition of neuropathic pain. Pain 2011 152 10 2204 2205 10.1016/j.pain.2011.06.017 21764514
    [Google Scholar]
  62. Sterne J.A.C. Savović J. Page M.J. Elbers R.G. Blencowe N.S. Boutron I. Cates C.J. Cheng H.Y. Corbett M.S. Eldridge S.M. Emberson J.R. Hernán M.A. Hopewell S. Hróbjartsson A. Junqueira D.R. Jüni P. Kirkham J.J. Lasserson T. Li T. McAleenan A. Reeves B.C. Shepperd S. Shrier I. Stewart L.A. Tilling K. White I.R. Whiting P.F. Higgins J.P.T. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 2019 366 l4898 10.1136/bmj.l4898 31462531
    [Google Scholar]
  63. Hashim N.A. Fathy H.A. Esawy M.M. Shabana M.A. Comparison of efficiency between platelet rich plasma and corticosteroid injection therapies in patients with Carpal tunnel syndrome: A prospective randomized controlled study. Egypt. J. Neurol. Psychiat. Neurosurg. 2020 56 1 59 10.1186/s41983‑020‑00184‑1
    [Google Scholar]
  64. Gado S.E. EL-Banna H.S. Efficacy of platelet-rich plasma injection in mild and moderate carpal tunnel syndrome: randomized control study. Egypt. Rheumatol. Rehabil. 2020 47 1 4 10.1186/s43166‑020‑00008‑3
    [Google Scholar]
  65. Bozkurt M. Tatar B.E. Karakol P. Sezgiç M. Uslu C. Solak H.T. Gelbal C. Matriderm and platelet-rich plasma combination in the treatment of recurrent carpal tunnel syndrome: A new approach. Eur. J. Plast. Surg. 2022 45 2 299 306 10.1007/s00238‑021‑01863‑9
    [Google Scholar]
  66. Senna M.K. Shaat R.M. Ali A.A.A. Platelet-rich plasma in treatment of patients with idiopathic carpal tunnel syndrome. Clin. Rheumatol. 2019 38 12 3643 3654 10.1007/s10067‑019‑04719‑7 31420812
    [Google Scholar]
  67. Eltabl M.A. Saif D.S. Alemam S.E. Platelet-rich plasma injection versus surgical and medical treatment of mild-moderate carpal tunnel syndrome. Egypt. J. Neurol. Psychiat. Neurosurg. 2020 56 1 88 10.1186/s41983‑020‑00186‑z
    [Google Scholar]
  68. Malahias M.A. Nikolaou V.S. Johnson E.O. Kaseta M.K. Kazas S.T. Babis G.C. Platelet‐rich plasma ultrasound‐guided injection in the treatment of carpal tunnel syndrome: A placebo‐controlled clinical study. J. Tissue Eng. Regen. Med. 2018 12 3 e1480 e1488 10.1002/term.2566 28873284
    [Google Scholar]
  69. Raeissadat S.A. Karimzadeh A. Hashemi M. Bagherzadeh L. Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial. BMC Musculoskelet. Disord. 2018 19 1 49 10.1186/s12891‑018‑1963‑4 29433485
    [Google Scholar]
  70. Wu Y.T. Ho T.Y. Chou Y.C. Ke M.J. Li T.Y. Huang G.S. Chen L.C. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. Sci. Rep. 2017 7 1 94 10.1038/s41598‑017‑00224‑6 28273894
    [Google Scholar]
  71. Uzdu A. Kirazlı Y. Karapolat H. Unlu B. Tanıgör G. Çalış F.A. Efficacy of platelet-rich plasma in the treatment of hemiplegic shoulder pain. Neurol. Sci. 2021 42 5 1977 1986 10.1007/s10072‑020‑04710‑0 32990858
    [Google Scholar]
  72. Anjayani S Widodo Wirohadidjojo Y Adam AM Suwandi D Seweng A Dali Amiruddin M Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. Int J Dermatol. 2014 53 1 109 13 10.1111/ijd.12162
    [Google Scholar]
  73. Xu Z. Wu S. Li X. Liu C. Fan S. Ma C. Ultrasound-Guided Transforaminal Injections of Platelet-Rich Plasma Compared with Steroid in Lumbar Disc Herniation: A Prospective, Randomized, Controlled Study. Neural Plast. 2021 2021 1 11 10.1155/2021/5558138 34135954
    [Google Scholar]
  74. Baron R. Binder A. Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010 9 8 807 819 10.1016/S1474‑4422(10)70143‑5 20650402
    [Google Scholar]
  75. Bernatoniene J. Sciupokas A. Kopustinskiene D.M. Petrikonis K. Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain. Pharmaceutics 2023 15 7 1799 10.3390/pharmaceutics15071799 37513986
    [Google Scholar]
  76. Moisset X. Bouhassira D. Attal N. French guidelines for neuropathic pain: An update and commentary. Rev. Neurol. (Paris) 2021 177 7 834 837 10.1016/j.neurol.2021.07.004 34332778
    [Google Scholar]
  77. Finnerup N.B. Attal N. Haroutounian S. McNicol E. Baron R. Dworkin R.H. Gilron I. Haanpää M. Hansson P. Jensen T.S. Kamerman P.R. Lund K. Moore A. Raja S.N. Rice A.S.C. Rowbotham M. Sena E. Siddall P. Smith B.H. Wallace M. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol. 2015 14 2 162 173 10.1016/S1474‑4422(14)70251‑0 25575710
    [Google Scholar]
  78. Xuan Z. Yu W. Dou Y. Wang T. Efficacy of Platelet-rich Plasma for Low Back Pain: A Systematic Review and Meta-analysis. J. Neurol. Surg. A Cent. Eur. Neurosurg. 2020 81 6 529 534 10.1055/s‑0040‑1709170 32438421
    [Google Scholar]
  79. Belk J.W. Kraeutler M.J. Houck D.A. Goodrich J.A. Dragoo J.L. McCarty E.C. Platelet-Rich Plasma versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Am. J. Sports Med. 2021 49 1 249 260 10.1177/0363546520909397 32302218
    [Google Scholar]
  80. Filardo G. Di Matteo B. Kon E. Merli G. Marcacci M. Platelet-rich plasma in tendon-related disorders: results and indications. Knee Surg. Sports Traumatol. Arthrosc. 2018 26 7 1984 1999 10.1007/s00167‑016‑4261‑4 27665095
    [Google Scholar]
  81. Wipperman J. Goerl K. Carpal Tunnel Syndrome: Diagnosis and Management. Am. Fam. Physician 2016 94 12 993 999 28075090
    [Google Scholar]
  82. Saraf A. Hussain A. Sandhu A.S. Bishnoi S. Arora V. Transforaminal Injections of Platelet-Rich Plasma Compared with Steroid in Lumbar radiculopathy: A Prospective, Double-Blind Randomized Study. Indian J. Orthop. 2023 57 7 1126 1133 10.1007/s43465‑023‑00898‑3 37384009
    [Google Scholar]
  83. Bise S. Dallaudiere B. Pesquer L. Pedram M. Meyer P. Antoun M.B. Hocquelet A. Silvestre A. Comparison of interlaminar CT-guided epidural platelet-rich plasma versus steroid injection in patients with lumbar radicular pain. Eur. Radiol. 2020 30 6 3152 3160 10.1007/s00330‑020‑06733‑9 32095875
    [Google Scholar]
  84. Le V.T. Nguyen Dao L.T. Nguyen A.M. Transforaminal injection of autologous platelet-rich plasma for lumbar disc herniation: A single-center prospective study in Vietnam. Asian J. Surg. 2023 46 1 438 443 10.1016/j.asjsur.2022.05.047 35637114
    [Google Scholar]
  85. Gupta A. Chhabra H.S. Singh V. Nagarjuna D. Lumbar Transforaminal Injection of Steroids versus Platelet-Rich Plasma for Prolapse Lumbar Intervertebral Disc with Radiculopathy: A Randomized Double-Blind Controlled Pilot Study. Asian Spine J. 2024 18 1 58 65 10.31616/asj.2023.0115 38433432
    [Google Scholar]
  86. Catapano M. Catapano J. Borschel G. Alavinia S.M. Robinson L.R. Mittal N. Effectiveness of Platelet-Rich Plasma Injections for Nonsurgical Management of Carpal Tunnel Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Arch. Phys. Med. Rehabil. 2020 101 5 897 906 10.1016/j.apmr.2019.10.193 31821797
    [Google Scholar]
  87. Dong C. Sun Y. Qi Y. Zhu Y. Wei H. Wu D. Li C. Effect of Platelet-Rich Plasma Injection on Mild or Moderate Carpal Tunnel Syndrome: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. BioMed Res. Int. 2020 2020 1 14 10.1155/2020/5089378 33274213
    [Google Scholar]
  88. Padua L. Coraci D. Erra C. Pazzaglia C. Paolasso I. Loreti C. Caliandro P. Hobson-Webb L.D. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016 15 12 1273 1284 10.1016/S1474‑4422(16)30231‑9 27751557
    [Google Scholar]
  89. Wang L. Guiding Treatment for Carpal Tunnel Syndrome. Phys. Med. Rehabil. Clin. N. Am. 2018 29 4 751 760 10.1016/j.pmr.2018.06.009 30293628
    [Google Scholar]
  90. Kang H.J. Jung S.H. Yoon H.K. Hahn S.B. Kim S.J. Carpal tunnel syndrome caused by space occupying lesions. Yonsei Med. J. 2009 50 2 257 261 10.3349/ymj.2009.50.2.257 19430560
    [Google Scholar]
  91. Allampallam K. Chakraborty J. Robinson J. Effect of ascorbic acid and growth factors on collagen metabolism of flexor retinaculum cells from individuals with and without carpal tunnel syndrome. J. Occup. Environ. Med. 2000 42 3 251 259 10.1097/00043764‑200003000‑00005 10738704
    [Google Scholar]
  92. Bohren Y. Timbolschi D.I. Muller A. Barrot M. Yalcin I. Salvat E. Platelet‐rich plasma and cytokines in neuropathic pain: A narrative review and a clinical perspective. Eur. J. Pain 2022 26 1 43 60 10.1002/ejp.1846 34288258
    [Google Scholar]
  93. Hirata H. Nagakura T. Tsujii M. Morita A. Fujisawa K. Uchida A. Effect of Ascorbic Acid and Growth Factors on Collagen Metabolism of Flexor Retinaculum Cells From Individuals With and Without Carpal Tunnel Syndrome. J. Pathol. 2004 204 605 612 10.1002/path.1673 15538733
    [Google Scholar]
  94. Lana J.F.S.D. Purita J. Paulus C. Huber S.C. Rodrigues B.L. Rodrigues A.A. Santana M.H. Madureira J.L. Jr Luzo Â.C.M. Belangero W.D. Annichino-Bizzacchi J.M. Contributions for classification of platelet rich plasma - Proposal of a new classification: MARSPILL. Regen. Med. 2017 12 5 565 574 10.2217/rme‑2017‑0042 28758836
    [Google Scholar]
  95. Pachito D.V. Bagattini Â.M. de Almeida A.M. Mendrone-Júnior A. Riera R. Technical Procedures for Preparation and Administration of Platelet-Rich Plasma and Related Products: A Scoping Review. Front. Cell Dev. Biol. 2020 8 598816 10.3389/fcell.2020.598816 33363154
    [Google Scholar]
  96. Le A.D.K. Enweze L. DeBaun M.R. Dragoo J.L. Current Clinical Recommendations for Use of Platelet-Rich Plasma. Curr. Rev. Musculoskelet. Med. 2018 11 4 624 634 10.1007/s12178‑018‑9527‑7 30353479
    [Google Scholar]
  97. Chahla J. Cinque M.E. Piuzzi N.S. Mannava S. Geeslin A.G. Murray I.R. Dornan G.J. Muschler G.F. LaPrade R.F. A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting. J. Bone Joint Surg. Am. 2017 99 20 1769 1779 10.2106/JBJS.16.01374 29040132
    [Google Scholar]
  98. Fadadu P.P. Mazzola A.J. Hunter C.W. Davis T.T. Review of concentration yields in commercially available platelet-rich plasma (PRP) systems: A call for PRP standardization. Reg. Anesth. Pain Med. 2019 44 6 652 659 10.1136/rapm‑2018‑100356 30992411
    [Google Scholar]
/content/journals/cdrr/10.2174/0125899775321724240926114704
Loading
Platelet-rich Plasma for the Treatment of Neuropathic Pain: A Systematic Review
Bentham Science Publishers ; https://doi.org/10.2174/0125899775321724240926114704
/content/journals/cdrr/10.2174/0125899775321724240926114704
/content/journals/cdrr/10.2174/0125899775321724240926114704
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article. Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: analgesia ; systematic review ; visual analog scale ; Neuropathic pain ; carpal tunnel syndrome ; platelet-rich plasma

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test